Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating the safety and effectiveness of CNTO6785 in adults with moderate to severe chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CNTO6785

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED